The Vanguard Group, Inc.: Disclosure on Mural Oncology plc

The Vanguard Group, Inc. has filed a Form 8.3 regarding its position in Mural Oncology plc, as per the Irish Takeover Panel rules. As of May 30, 2025, Vanguard holds interests in Mural's $0.01 ordinary shares, amounting to 772,867 shares or 4.48% of the total. This disclosure follows the rules enacted by the Irish Takeover Panel Act of 1997 and subsequent takeover rules of 2022.

No additional information about other parties to the offer was provided beyond Mural Oncology plc, nor were there any relevant dealings in cash-settled or stock-settled derivatives. Vanguard executed a minor transaction, selling 18 shares at a price of 2.62 USD per unit. No indemnity or option arrangements, agreements or understandings related to voting rights were reported.